McMaster, Sartorius embark on antibody, virus-based treatment research

McMaster University and Sartorius Stedim Biotech have partnered to improve the manufacturing processes of antibody and virus-based treatment for diseases such as COVID-19, cancers, and genetic disorders. McMaster will use a state-of-the-art, multi-column chromatography system provided by Sartorius to perfect the process for purifying therapeutic viruses, which will create the opportunity for new, affordable treatments for patients. "Teaming up with Sartorius Stedim Biotech is an exciting opportunity for McMaster Engineering,” said John Preston, associate dean, research, innovation and external relations in the Faculty of Engineering. “This research will push the envelope in leading advanced, cutting-edge research in bio-manufacturing," Newswire (ON)